scholarly journals Impact of Visceral Fat Area Measured by Bioelectrical Impedance Analysis on Clinico-Pathologic Outcomes of Colorectal Surgery

2021 ◽  
Vol 13 (1) ◽  
pp. 17-23
Author(s):  
Kyeong Eui Kim ◽  
Woo Jin Song ◽  
Minji Seok ◽  
Sung Uk Bae ◽  
Woon Kyung Jeong ◽  
...  
2021 ◽  
Vol 36 (1) ◽  
pp. 97-105
Author(s):  
Han Ho Jeon ◽  
Yong Kang Lee ◽  
Dong Hyun Kim ◽  
Haeyong Pak ◽  
Sang Yun Shin ◽  
...  

2020 ◽  
Vol 16 (5) ◽  
pp. 515-519 ◽  
Author(s):  
Hidetaka Hamasaki ◽  
Masashi Furuta ◽  
Hidekatsu Yanai

Introduction: Obesity management is a critical global issue. It is essential to evaluate visceral adiposity which is associated with metabolic syndrome and cardiovascular disease. Aim: This study aims at precisely evaluating the necessity of visceral adipose tissue in obesity management. Methods: We assessed the validity of visceral fat area (VFA) measurement using bioelectrical impedance analysis (BIA) with computed tomography (CT) as a reference in obese subjects. Although VFABIA exhibited significant correlation with VFACT, the difference between VFACT and VFABIA increased with an advancing degree of obesity. Result and Conclusion: The BIA device seemingly underestimated VFA in obese subjects compared with the normal-weight subjects.


2019 ◽  
Vol 18 (1) ◽  
Author(s):  
Yoko Omura-Ohata ◽  
Cheol Son ◽  
Hisashi Makino ◽  
Ryo Koezuka ◽  
Mayu Tochiya ◽  
...  

Abstract Background Visceral fat area (VFA) is a good surrogate marker of obesity-related disorders, such as hypertension, dyslipidemia and glucose intolerance. Although estimating the VFA by X-ray computed tomography (CT) is the primary index for visceral obesity, it is expensive and requires invasive radiation exposure. Dual bioelectrical impedance analysis (BIA) is a simple and reliable method to estimate VFA; however, the clinical usefulness of dual BIA remains unclear in patients with type 2 diabetes (T2D). Methods We estimated the VFAs by dual BIA and CT in 98 patients with T2D and assessed anthropometric parameters, blood test results, and the presence of comorbid hypertension and dyslipidemia. We compared the correlation between the VFAs examined by dual BIA and CT. Furthermore, we performed the receiver operating characteristic (ROC) analyses for the VFAs to detect the presence of comorbid hypertension and/or dyslipidemia with T2D, which are major comorbidities of visceral obesity, and estimated the area under the curve (AUC). Results The measurement error between the VFAs by dual BIA and CT was significantly higher among patients with brain natriuretic peptide (BNP) ≥ 100 pg/mL than those with BNP < 100 pg/mL (39.2% ± 31.1% vs. 24.1% ± 18.6%, P < 0.05). After excluding patients with BNP ≥ 100 pg/mL, the VFA by dual BIA significantly correlated with the VFA by CT (r = 0.917; P < 0.0001). The AUC in the ROC analysis for the VFA by dual BIA to detect the presence of comorbid hypertension and/or dyslipidemia with T2D was almost equivalent to that for the VFA by CT. Conclusions In patients with T2D without elevated BNP > 100 pg/mL as indicator for fluid accumulation interfering with BIA, estimation of the VFA by dual BIA significantly correlated with that by CT and also detected comorbid hypertension and/or dyslipidemia with T2D equivalent to those detected by CT. Hence, dual BIA could be an alternative to CT as a standard method for estimating the VFA in patients with diabetes.


Sign in / Sign up

Export Citation Format

Share Document